Top

International Journal of Diabetes in Developing Countries

Published in:

01-12-2013 | Original Article

Polymorphisms in Mn-SOD and EC-SOD gene and risk of nephropathy in Western Indian Type 2 diabetic patients

Authors: Hitesh Vashrambhai Patel, Kiran Kalia

Published in: International Journal of Diabetes in Developing Countries | Issue 4/2013

Abstract

Single-nucleotide polymorphisms in genes related to oxidative stress are a risk factor for the development of diabetes and its complications. The allele and genotype frequencies of missense polymorphism Ala-9Val and Val16Ala in Mn-SOD and Arg213Gly in EC-SOD genes were studied in (a) patients with Type 2 diabetes mellitus (T2DM) without any complication (T2DM), (b) diabetic nephropathy (DN), (c) non-diabetic nephropathy (NDN) and (d) control healthy subjects from Western region of India. The PCR products were digested with BshTI, BsaWI and Eco52I restriction enzymes to detect Ala-9Val, Val16Ala and Arg213Gly polymorphisms respectively. The frequency of Val allele of Ala-9Val (P = 0.568 and P = 0.571) and Ala allele of Val16Ala (P = 0.993 and P = 0.152) polymorphisms of Mn-SOD gene did not show a significant difference in patient with T2DM and NDN compared to control subjects respectively. Frequency of Val allele of Ala-9Val (42.8 % vs. 61.5 %, P < 0.001) and Ala allele of Val16Ala (39.0 % vs. 53.5 %, P = 0.005) polymorphisms of Mn-SOD gene was significantly higher in patients with DN than that of patient with T2DM. For Arg213Gly polymorphism of EC-SOD gene, the Gly allele frequency in T2DM and NDN group did not significantly (P = 0.993 and P = 0.152 respectively) differ from control subjects as well as non-significantly higher in DN compared to T2DM. These results suggests that Ala-9Val and Val16Ala polymorphism in Mn-SOD is not involved in development of diabetes but may play a crucial role in determining genetic susceptibility to diabetic nephropathy in Western Indian Type 2 diabetic patients. Our data found a lack of association of EC-SOD (Arg213Gly) polymorphism with development of diabetes and diabetic nephropathy.

King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21:1414–31.PubMedCrossRef

Goldstein BJ. Insulin resistance: from benign to type 2 diabetes mellitus. Rev Cardiovasc Med. 2003;4:S3–10.PubMed

Dalla VM, Saller A, Bortoloso E, Mauer M, Fioretto P. Structural involvement in type 1 and type 2 diabetic nephropathy. Diabetes Metab. 2000;26:8–14.

Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care. 2005;28:164–76.PubMedCrossRef

American Diabetes Association. Diabetic nephropathy. Diabetes Care. 2002;25(Supplement)1:S85–S89.

Dave GS, Kalia K. Hyperglycemia, reactive oxygen species and pathophysiology of diabetic nephropathy. J Cell Tissue Res. 2008;8:1367–77.

Rolo AP, Palmeira CM. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicol Appl Pharmacol. 2006;212:167–78.PubMedCrossRef

Flekac M, Skrha J, Hilgertova J, Lacinova Z, Jarolimkova M. Gene polymorphisms of superoxide dismutases and catalase in diabetes mellitus. BMC Med Genet. 2008;9:30.PubMedCentralPubMedCrossRef

Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev. 2002;23:599–622.PubMedCrossRef

10.

Seaquist ER, Goetz FC, Rich S, Barbosa J. Familial clustering of diabetic kidney disease: evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med. 1989;320:1161–4.PubMedCrossRef

11.

Hansen L, Pedersen O. Genetics of type 2 diabetes mellitus: status and perspectives. Diabetes Obes Metab. 2005;7:122–35.PubMedCrossRef

12.

Chowdhury TA, Dyer PH, Kumar S, Barnett AH, Bain SC. Genetic determinants of diabetic nephropathy. Clin Sci. 1999;96:221–30.PubMedCrossRef

13.

Maritim AC, Sanders RA, Watkins JB. 3rd diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol. 2003;17:24–38.PubMedCrossRef

14.

Zelko IN, Mariani TJ, Folz RJ. Superoxide dismutase multigene family: a comparisons of the CuZn-SOD (SOD1), Mn-SOD (SOD2), AND EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic Biol Med. 2002;33:337–49.PubMedCrossRef

15.

Rosenblum JS, Gilula NB, Lerner RA. On signal sequence polymorphisms and diseases of distribution. Proc Natl Acad Sci U S A. 1996;93:4471–3.PubMedCentralPubMedCrossRef

16.

Shimoda-Matsubayashi S, Matsumine H, Kobayashi T, Nakagawa-Hattori Y, Shimizu Y, Mizuno Y. Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. A predictive evidence for conformational change to influence mitochondrial transport and a study of allelic association in Parkinson’s disease. Biochem Biophys Res Commun. 1996;226:561–5.PubMedCrossRef

17.

Chistyakov DA, Savost’anov KV, Zotova EV, Nosikov VV. Polymorphisms in the Mn-SOD and EC-SOD genes and their relationship to diabetic neuropathy in type 1 diabetes mellitus. BMC Med Genet. 2001;2:4.PubMedCentralPubMedCrossRef

18.

Patel HV, Kalia K, Mannari J. Angiotensin converting enzyme (ACE) gene polymorphism increases the susceptibility of diabetic nephropathy in Western Indian Type 2 diabetic patients. Int J Diab Dev Ctries. 2011;31:223–9.CrossRef

19.

Mathew CGP. The isolation of high molecular weight eukaryotic DNA. In Walker J, (editor). Methods of mol biol. Vol. 2. Humana Press; 1984. pp. 31–34.

20.

Elsakka NE, Webster NR, Galley HF. Polymorphism in the manganese superoxide dismutase gene. Free Radic Res. 2007;41:770–8.PubMedCrossRef

21.

Tiwari AK, Prasad P, Thelma BK, Prasanna Kumar KM, Ammini AC, Gupta A, et al. Oxidative stress pathway genes and chronic renal insufficiency in Asian Indians with type 2 diabetes. J Diabetes Complicat. 2009;23:102–11.PubMedCrossRef

22.

Liu L, Zheng T, Wang N, Wang F, Li M, Jiang J, et al. The manganese superoxide dismutase Val16Ala polymorphism is associated with decreased risk of diabetic nephropathy in Chinese patients with type 2 diabetes. Mol Cell Biochem. 2009;322:87–91.PubMedCrossRef

23.

Lee SJ, Choi MG, Kim DS, Kim TW. Manganese superoxide dismutase gene polymorphism (V16A) is associated with stages of albuminuria in Korean type 2 diabetic patients. Metabolism. 2006;55:1–7.PubMedCrossRef

24.

Zotova EV, Chistyakov DA, Savost’yanov EV, Bursa TR, Galeev IV, Strokov IA, et al. Association of the SOD2 Ala(−9)Val and SOD3 Arg213Gly polymorphisms with diabetic polyneuropathy in diabetes mellitus type 1. Mol Biol. 2003;37:345–8.CrossRef

25.

Nomiyama T, Tanaka Y, Piao L, Nagasaka K, Sakai K, Ogihara T, et al. The polymorphism of manganese superoxide dismutase is associated with diabetic nephropathy in Japanese type 2 diabetic patients. J Hum Genet. 2003;48:138–41.PubMed

26.

Van Landeghem GF, Tabatabaie P, Kucinskas V, Saha N, Beckman G. Ethnic variation in the mitochondrial targeting sequence polymorphism of MnSOD. Hum Hered. 1999;49:190–3.PubMedCrossRef

27.

Hori H, Ohmori O, Shinkai T, Kojima H, Okano C, Suzuki T, et al. Manganese superoxide dismutase gene polymorphism and schizophrenia: relation to tardive dyskinesia. Neuropsychopharmacology. 2000;23:170–7.PubMedCrossRef

28.

Adachi T, Ohta H, Hirano K, Hayashi K, Marklund SL. Non enzymatic glycation of human extracellular superoxide dismutase. Biochem J. 1991;279:263–7.PubMed

29.

Tamai MT, Furuta H, Kawashima H, Doi A, Hamanishi T, Shimomura H, et al. Extracellular superoxide dismutase gene polymorphism is associated with insulin resistance and the susceptibility to type 2 diabetes. Diabetes Res Clin Pract. 2006;71:140–5.PubMedCrossRef

30.

Fujita H, Fujishima H, Chida S, Takahashi K, Qi Z, Kanetsuna Y, et al. Reduction of renal superoxide dismutase in progressive diabetic nephropathy. J Am Soc Nephrol. 2009;20:1303–13.PubMedCrossRef

Title: Polymorphisms in Mn-SOD and EC-SOD gene and risk of nephropathy in Western Indian Type 2 diabetic patients
Authors: Hitesh Vashrambhai Patel
Kiran Kalia
Publication date: 01-12-2013
Publisher: Springer India
Published in: International Journal of Diabetes in Developing Countries / Issue 4/2013
Print ISSN: 0973-3930
Electronic ISSN: 1998-3832
DOI: https://doi.org/10.1007/s13410-013-0156-9

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Polymorphisms in Mn-SOD and EC-SOD gene and risk of nephropathy in Western Indian Type 2 diabetic patients

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2013

Association of the polymorphism of interleukin-1B (−511C/T) with type 2 diabetes mellitus patients with and without family history of a first degree relative with diabetes mellitus

Permanent neonatal diabetes due to a novel L105P (c.314T>C; p.Leu105Pro) heterozygous mutation in insulin gene

mtDNA 16184–16193 poly-C tract does not predispose to type 2 diabetes in the Mauritanian population

Polymorphisms in PPARγ (Pro12Ala, C1431T), IRS1 (G972R), IRS2 (G1057D) and Coronary artery disease

Type 2 diabetes mellitus (T2DM) subjects of Bangladeshi origin with fast N-acetyltransferase 2 (NAT2) acetylator phenotype show lower insulin sensitivity than slow acetylator phenotype

Role of the rs9939609 gene variant of FTO on cardiovascular risk factors and adipokines levels in naive patients with diabetes mellitus type 2

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page